ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

ngµç×ÓÓÎÏ·Ç®¾ü½ÌÊÚÍŶÓÕ¹ÏÖ°£²©À­²¡¶¾¡°ÓÅÊÆ¡±Í»±ä£¬£¬£¬ÎªÒßÇé·À¿ØÓëÒ©ÎïÑз¢Ìṩ¿ÆÑ§ÒÀ¾Ý

¸å¼þȪԴ£º £º£º¹«¹²ÎÀÉúѧԺ£¨ÉîÛÚ£© ±à¼­£º £º£ºÓàæÃ ÉóºË£º £º£ºËïÒ«±ó ÔĶÁÁ¿£º £º£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ºÎ¼ÎÃô)2026Äê1ÔÂ23ÈÕ£¬£¬£¬ngµç×ÓÓÎÏ·Ç®¾ü½ÌÊÚÍŶÓÁªºÏ¹ãÖÝÒ½¿Æ´óѧÁ¥ÊôÊаËÒ½ÔºÁõÁÖÄȽÌÊÚÍŶÓ¡¢¡¢¡¢¼ªÁÖ´óѧµÚÒ»Ò½ÔºÁõÈ«½ÌÊÚÍŶÓÒÔ¼°ngµç×ÓÓÎÏ·ÑÈÙ½ÌÊÚÍŶÓ£¬£¬£¬ÔÚCellÉϽÒÏþÁËÌâΪ¡°Molecular characterization of Ebola virus glycoprotein V75A substitution in the 2018¨C2020 epidemic¡±µÄÑо¿ÂÛÎÄ¡£¡£¡£¸ÃÑо¿Õ¹ÏÖÁË2018-2020Äê°£²©À­ÒßÇéÖзºÆðµÄÓÅÊÆÍ»±äGP-V75A£¬£¬£¬²¢ÆÊÎöÁ˸ÃÍ»±äÔöÇ¿²¡¶¾Ñ¬È¾ÐԵķÖ×Ó»úÖÆ¡£¡£¡£

Ñо¿ÍŶӶÔ480ÌõEBOVÈ«»ùÒò×é¾ÙÐÐÆÊÎö£¬£¬£¬·¢Ã÷Я´øÌÇÂѰ×GP-V75AÍ»±äµÄ¶¾ÖêÔÚÒßÇéÔçÆÚ·ºÆð£¬£¬£¬Ö®ºóѸËÙÈ¡´úԭʼ¶¾Ö꣬£¬£¬ÆäÊ¢ÐÐÇ÷ÊÆÓ벡Àý¼¤Ôö¸ß¶ÈÖØºÏ£¬£¬£¬ÌáÐѸÃÍ»±ä¿ÉÄÜÌá¸ßÁ˲¡¶¾µÄÈö²¥ÓÅÊÆ¡£¡£¡£ÎªÑéÖ¤ÆäÉúÎïѧЧӦ£¬£¬£¬ÍŶÓʹÓöàÖÖʵÑéÄ£×Ó¿ªÕ¹Ñо¿£¬£¬£¬Ð§¹ûÅú×¢¸ÃÍ»±äÄÜÏÔÖøÔöÇ¿EBOV¶Ô¶àÖÖËÞÖ÷ϸ°û¼°Ð¡ÊóµÄѬȾÄÜÁ¦¡£¡£¡£»£»úÖÆÑо¿·¢Ã÷£¬£¬£¬¸ÃÍ»±äͨ¹ýÎȹÌÂѰ׹¹ÏóÔöÇ¿GPÓ벡¶¾ÊÜÌåNPC1µÄÁ¬Ïµ£¬£¬£¬Í¬Ê±½µµÍ²¡¶¾½øÈëϸ°ûʱ¶ÔËÞÖ÷×éÖ¯ÂѰ×øµÄÒÀÀµ¡£¡£¡£±ðµÄ£¬£¬£¬Ñо¿»¹·¢Ã÷¸ÃÍ»±äÄܹ»Ï÷Èõ²¿·ÖÏÖÓÐÖÎÁÆÐÔ¿¹Ì弰С·Ö×Ó½øÈëÒÖÖÆ¼ÁµÄ¿¹²¡¶¾Ð§¹û£¬£¬£¬ÌáÐÑGP-V75AÍ»±ä¿ÉÄÜ´øÀ´ÄÍÒ©·çÏÕ¡£¡£¡£

154C58448CAC4406690336B9DAA_EE032FFC_2F748


±¾Ñо¿²»µ«ÆÊÎöÁËGP-V75AÍ»±äÔÚEVDÒßÇéÈö²¥ÖеÄÒªº¦×÷Ó㬣¬£¬Ò²Í¹ÏÔÁËÔÚÖØ´óÒßÇéÖпªÕ¹ÊµÊ±²¡¶¾»ùÒò×é¼à²âµÄÖ÷ÒªÐÔ£¬£¬£¬²¢ÎªÎ´À´¿ª·¢¹ãÆ×¿¹EBOVÕ½ÂÔÌṩÁË¿ÆÑ§ÒÀ¾Ý¡£¡£¡£

Ç®¾ü½ÌÊÚΪ×îºóͨѶ×÷Õߣ¬£¬£¬ÁõÁÖÄȽÌÊÚ¡¢¡¢¡¢ÁõÈ«½ÌÊÚºÍÑÈÙ½ÌÊÚΪÅäºÏͨѶ×÷Õß¡£¡£¡£ngµç×ÓÓÎÏ·¹«¹²ÎÀÉúѧԺ£¨ÉîÛÚ£©²©Ê¿ºó·¶ÁÖ½ø¡¢¡¢¡¢¹ãÖÝÒ½¿Æ´óѧÁ¥ÊôÊаËÒ½Ôº²©Ê¿ºóÍõÓêÁú¡¢¡¢¡¢ngµç×ÓÓÎÏ·ÖÐɽҽѧԺ²©Ê¿ÉúÍõÓ¢ºÀΪÅäºÏµÚÒ»×÷Õß¡£¡£¡£


ÂÛÎÄÁ´½Ó£º £º£ºhttps://doi.org/10.1016/j.cell.2025.12.022


¡¾ÍøÕ¾µØÍ¼¡¿